Aim Bulletin

AOTI diabetic foot ulcer therapy gets reimbursement nod in Germany

By Josh White

Date: Monday 23 Jun 2025

(Sharecast News) - AOTI announced on Monday that its Topical Wound Oxygen (TWO2) therapy has received a positive reimbursement recommendation from Germany's Federal Joint Committee (G-BA).
The AIM-traded firm said the G-BA decision meant Germany was set to become the first country to grant full national reimbursement coverage for TWO2 therapy...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page